COMMON WARTS
Clinical trials for COMMON WARTS explained in plain language.
Never miss a new study
Get alerted when new COMMON WARTS trials appear
Sign up with your email to follow new studies for COMMON WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier YCANTH wart studies. It tests whether up to 4 more treatments, applied every 21 days, can safely clear common warts. About 600 adults and children will be monitored for a year. The goal is to see if the medicine continues…
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel can clear all warts by day 84.
Matched conditions: COMMON WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Pain-Free wart cream for kids shows promise in new study
Symptom relief Recruiting nowThis study tests whether a cream containing two medicines (5-fluorouracil and calcipotriol) can safely and effectively treat warts on the palms and soles of children aged 4 to 18. About 60 children will receive either the active cream or a placebo for several weeks. The goal is t…
Matched conditions: COMMON WARTS
Phase: NA • Sponsor: Mazandaran University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC